# Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion

> **NCT05264727** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 30 (actual)

## Conditions studied

- Healthy
- Type 2 Diabetes
- Obesity

## Interventions

- **DRUG:** Dextrose
- **DRUG:** Clinisol 15%

## Key facts

- **NCT ID:** NCT05264727
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-30
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05264727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05264727, "Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05264727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*